ESMOVEK-L is used for comprehensive treatment of acid-related disorders. It reduces gastric acid secretion and improves digestion. The formulation is effective in GERD, dyspepsia, and peptic ulcers. ESMOVEK-L provides rapid and reliable symptom relief. Well tolerated for prolonged therapy.
ESMOVEK-L is a dual-action therapy formulated to deliver effective acid suppression along with enhanced gastric motility, providing comprehensive relief in acid-peptic and reflux disorders.
Clinical advantages designed for effective acid control and digestive comfort
Rapid and sustained relief from acidity and heartburn
Controls reflux symptoms and prevents recurrence
Improves digestion by correcting motility disorders
Promotes healing of acid-induced mucosal damage
Well-tolerated combination for long-term management
Esomeprazole A proton pump inhibitor that reduces gastric acid secretion Promotes healing of esophageal and gastric mucosa Provides long-lasting control of acid production
Levosulpiride Improves gastric motility and accelerates gastric emptying Reduces bloating, early satiety, and functional dyspepsia symptoms Enhances overall digestive comfort
ESMOVEK-L is indicated for management of acid-related and gastrointestinal disorders.